Description

Ranitidin-Darnitsa Coated Tablets 0.15 g. №20

Ingredients:

• Each coated tablet contains 0.15 g of Ranitidine.

Dosage:

• The usual dosage is one tablet orally twice a day.

Indications:

• Ranitidin-Darnitsa is indicated for the treatment of duodenal ulcers, benign gastric ulcers, reflux esophagitis, and Zollinger-Ellison syndrome.

Contraindications:

• Do not use Ranitidin-Darnitsa if you are allergic to ranitidine or any other ingredients in the product.

Directions:

• Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Mechanism of Action:

• Ranitidine, the active ingredient in Ranitidin-Darnitsa, is a histamine-2 receptor antagonist that works by reducing the amount of acid produced by the stomach.

Pharmacological Properties:

• Studies have demonstrated the efficacy of ranitidine in treating various gastrointestinal conditions.

Comparative Effectiveness:

• Ranitidine has been shown to be as effective as other commonly used medications in the treatment of ulcers and gastroesophageal reflux disease.

Additional Information:

• Ranitidin-Darnitsa coated tablets provide effective relief from acid-related conditions and are well-tolerated by most patients.
• It is important to follow the prescribed dosage and consult a healthcare professional if you have any concerns or experience adverse reactions.
• Ranitidine is considered a safe and cost-effective option for managing gastrointestinal conditions.